List of Tables
Table 1. Global Treatment Drugs for Axial Spondyloarthritis Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Treatment Drugs for Axial Spondyloarthritis Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Treatment Drugs for Axial Spondyloarthritis Market Competitive Situation by Manufacturers in 2025
Table 4. Global Treatment Drugs for Axial Spondyloarthritis Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Treatment Drugs for Axial Spondyloarthritis Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Treatment Drugs for Axial Spondyloarthritis Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Treatment Drugs for Axial Spondyloarthritis Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Treatment Drugs for Axial Spondyloarthritis, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Treatment Drugs for Axial Spondyloarthritis, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Treatment Drugs for Axial Spondyloarthritis, Product Types and Applications
Table 12. Global Key Manufacturers of Treatment Drugs for Axial Spondyloarthritis, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Treatment Drugs for Axial Spondyloarthritis Companies by Tier (Tier 1, Tier 2, Tier 3), based on Treatment Drugs for Axial Spondyloarthritis Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Treatment Drugs for Axial Spondyloarthritis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Treatment Drugs for Axial Spondyloarthritis Sales by Region (K Units), 2021–2026
Table 18. Global Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Region (2021–2026)
Table 19. Global Treatment Drugs for Axial Spondyloarthritis Sales by Region (K Units), 2027–2032
Table 20. Global Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Region (2027–2032)
Table 21. Global Treatment Drugs for Axial Spondyloarthritis Revenue by Region (US$ Million), 2021–2026
Table 22. Global Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Region (2021–2026)
Table 23. Global Treatment Drugs for Axial Spondyloarthritis Revenue by Region (US$ Million), 2027–2032
Table 24. Global Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Region (2027–2032)
Table 25. North America Treatment Drugs for Axial Spondyloarthritis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Treatment Drugs for Axial Spondyloarthritis Sales by Country (K Units), 2021–2026
Table 27. North America Treatment Drugs for Axial Spondyloarthritis Sales by Country (K Units), 2027–2032
Table 28. North America Treatment Drugs for Axial Spondyloarthritis Revenue by Country (US$ Million), 2021–2026
Table 29. North America Treatment Drugs for Axial Spondyloarthritis Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Treatment Drugs for Axial Spondyloarthritis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Treatment Drugs for Axial Spondyloarthritis Sales by Country (K Units), 2021–2026
Table 32. Europe Treatment Drugs for Axial Spondyloarthritis Sales by Country (K Units), 2027–2032
Table 33. Europe Treatment Drugs for Axial Spondyloarthritis Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Treatment Drugs for Axial Spondyloarthritis Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Treatment Drugs for Axial Spondyloarthritis Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Treatment Drugs for Axial Spondyloarthritis Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Treatment Drugs for Axial Spondyloarthritis Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Treatment Drugs for Axial Spondyloarthritis Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Treatment Drugs for Axial Spondyloarthritis Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Treatment Drugs for Axial Spondyloarthritis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Treatment Drugs for Axial Spondyloarthritis Sales by Country (K Units), 2021–2026
Table 42. Latin America Treatment Drugs for Axial Spondyloarthritis Sales by Country (K Units), 2027–2032
Table 43. Latin America Treatment Drugs for Axial Spondyloarthritis Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Treatment Drugs for Axial Spondyloarthritis Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Treatment Drugs for Axial Spondyloarthritis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Treatment Drugs for Axial Spondyloarthritis Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Treatment Drugs for Axial Spondyloarthritis Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Treatment Drugs for Axial Spondyloarthritis Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Treatment Drugs for Axial Spondyloarthritis Revenue by Country (US$ Million), 2027–2032
Table 50. Global Treatment Drugs for Axial Spondyloarthritis Sales (K Units) by Type (2021–2026)
Table 51. Global Treatment Drugs for Axial Spondyloarthritis Sales (K Units) by Type (2027–2032)
Table 52. Global Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Type (2021–2026)
Table 53. Global Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Type (2027–2032)
Table 54. Global Treatment Drugs for Axial Spondyloarthritis Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Treatment Drugs for Axial Spondyloarthritis Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Type (2021–2026)
Table 57. Global Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Type (2027–2032)
Table 58. Global Treatment Drugs for Axial Spondyloarthritis Price (US$/Unit) by Type (2021–2026)
Table 59. Global Treatment Drugs for Axial Spondyloarthritis Price (US$/Unit) by Type (2027–2032)
Table 60. Global Treatment Drugs for Axial Spondyloarthritis Sales (K Units) by Application (2021–2026)
Table 61. Global Treatment Drugs for Axial Spondyloarthritis Sales (K Units) by Application (2027–2032)
Table 62. Global Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Application (2021–2026)
Table 63. Global Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Application (2027–2032)
Table 64. Global Treatment Drugs for Axial Spondyloarthritis Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Treatment Drugs for Axial Spondyloarthritis Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Application (2021–2026)
Table 67. Global Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Application (2027–2032)
Table 68. Global Treatment Drugs for Axial Spondyloarthritis Price (US$/Unit) by Application (2021–2026)
Table 69. Global Treatment Drugs for Axial Spondyloarthritis Price (US$/Unit) by Application (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bayer Treatment Drugs for Axial Spondyloarthritis Product
Table 74. Bayer Recent Developments/Updates
Table 75. Novacap Company Information
Table 76. Novacap Description and Business Overview
Table 77. Novacap Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novacap Treatment Drugs for Axial Spondyloarthritis Product
Table 79. Novacap Recent Developments/Updates
Table 80. Abbott Company Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Abbott Treatment Drugs for Axial Spondyloarthritis Product
Table 84. Abbott Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Pfizer Treatment Drugs for Axial Spondyloarthritis Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Johnson & Johnson Treatment Drugs for Axial Spondyloarthritis Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Cigna Company Information
Table 96. Cigna Description and Business Overview
Table 97. Cigna Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Cigna Treatment Drugs for Axial Spondyloarthritis Product
Table 99. Cigna Recent Developments/Updates
Table 100. Geri-Care Pharmaceuticals Company Information
Table 101. Geri-Care Pharmaceuticals Description and Business Overview
Table 102. Geri-Care Pharmaceuticals Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Geri-Care Pharmaceuticals Treatment Drugs for Axial Spondyloarthritis Product
Table 104. Geri-Care Pharmaceuticals Recent Developments/Updates
Table 105. Perrigo Company Company Information
Table 106. Perrigo Company Description and Business Overview
Table 107. Perrigo Company Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Perrigo Company Treatment Drugs for Axial Spondyloarthritis Product
Table 109. Perrigo Company Recent Developments/Updates
Table 110. Kopran Company Information
Table 111. Kopran Description and Business Overview
Table 112. Kopran Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Kopran Treatment Drugs for Axial Spondyloarthritis Product
Table 114. Kopran Recent Developments/Updates
Table 115. Merck Sharp & Dohme Company Information
Table 116. Merck Sharp & Dohme Description and Business Overview
Table 117. Merck Sharp & Dohme Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Merck Sharp & Dohme Treatment Drugs for Axial Spondyloarthritis Product
Table 119. Merck Sharp & Dohme Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Company Information
Table 121. Sun Pharmaceutical Industries Description and Business Overview
Table 122. Sun Pharmaceutical Industries Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sun Pharmaceutical Industries Treatment Drugs for Axial Spondyloarthritis Product
Table 124. Sun Pharmaceutical Industries Recent Developments/Updates
Table 125. GlaxoSmithKline Company Information
Table 126. GlaxoSmithKline Description and Business Overview
Table 127. GlaxoSmithKline Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. GlaxoSmithKline Treatment Drugs for Axial Spondyloarthritis Product
Table 129. GlaxoSmithKline Recent Developments/Updates
Table 130. Reddy Pharmaceuticals Company Information
Table 131. Reddy Pharmaceuticals Description and Business Overview
Table 132. Reddy Pharmaceuticals Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Reddy Pharmaceuticals Treatment Drugs for Axial Spondyloarthritis Product
Table 134. Reddy Pharmaceuticals Recent Developments/Updates
Table 135. Verywell Company Information
Table 136. Verywell Description and Business Overview
Table 137. Verywell Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Verywell Treatment Drugs for Axial Spondyloarthritis Product
Table 139. Verywell Recent Developments/Updates
Table 140. UCB Company Information
Table 141. UCB Description and Business Overview
Table 142. UCB Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. UCB Treatment Drugs for Axial Spondyloarthritis Product
Table 144. UCB Recent Developments/Updates
Table 145. Novartis Company Information
Table 146. Novartis Description and Business Overview
Table 147. Novartis Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Novartis Treatment Drugs for Axial Spondyloarthritis Product
Table 149. Novartis Recent Developments/Updates
Table 150. Eli Lilly and Co. Company Information
Table 151. Eli Lilly and Co. Description and Business Overview
Table 152. Eli Lilly and Co. Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Eli Lilly and Co. Treatment Drugs for Axial Spondyloarthritis Product
Table 154. Eli Lilly and Co. Recent Developments/Updates
Table 155. AstraZeneca Company Information
Table 156. AstraZeneca Description and Business Overview
Table 157. AstraZeneca Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. AstraZeneca Treatment Drugs for Axial Spondyloarthritis Product
Table 159. AstraZeneca Recent Developments/Updates
Table 160. DICE Therapeutics Company Information
Table 161. DICE Therapeutics Description and Business Overview
Table 162. DICE Therapeutics Treatment Drugs for Axial Spondyloarthritis Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. DICE Therapeutics Treatment Drugs for Axial Spondyloarthritis Product
Table 164. DICE Therapeutics Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Treatment Drugs for Axial Spondyloarthritis Distributors List
Table 168. Treatment Drugs for Axial Spondyloarthritis Customers List
Table 169. Treatment Drugs for Axial Spondyloarthritis Market Trends
Table 170. Treatment Drugs for Axial Spondyloarthritis Market Drivers
Table 171. Treatment Drugs for Axial Spondyloarthritis Market Challenges
Table 172. Treatment Drugs for Axial Spondyloarthritis Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Treatment Drugs for Axial Spondyloarthritis
Figure 2. Global Treatment Drugs for Axial Spondyloarthritis Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Treatment Drugs for Axial Spondyloarthritis Market Share by Type: 2025 & 2032
Figure 4. Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Product Picture
Figure 5. Tumor necrosis Factor (TNF) Antagonists Product Picture
Figure 6. Interleukin-17 (IL-17) Inhibitors Product Picture
Figure 7. Janus Kinase (JAK) Inhibitors Product Picture
Figure 8. Global Treatment Drugs for Axial Spondyloarthritis Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Treatment Drugs for Axial Spondyloarthritis Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Treatment Drugs for Axial Spondyloarthritis Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Treatment Drugs for Axial Spondyloarthritis Market Size (US$ Million), 2021–2032
Figure 15. Global Treatment Drugs for Axial Spondyloarthritis Sales (K Units), 2021–2032
Figure 16. Global Treatment Drugs for Axial Spondyloarthritis Average Price (US$/Unit), 2021–2032
Figure 17. Treatment Drugs for Axial Spondyloarthritis Report Years Considered
Figure 18. Treatment Drugs for Axial Spondyloarthritis Sales Share by Manufacturers in 2025
Figure 19. Global Treatment Drugs for Axial Spondyloarthritis Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Treatment Drugs for Axial Spondyloarthritis Players: Market Share by Revenue in Treatment Drugs for Axial Spondyloarthritis in 2025
Figure 21. Treatment Drugs for Axial Spondyloarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Treatment Drugs for Axial Spondyloarthritis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Country (2021–2032)
Figure 24. North America Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Country (2021–2032)
Figure 25. United States Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Country (2021–2032)
Figure 28. Europe Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Country (2021–2032)
Figure 29. Germany Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Region (2021–2032)
Figure 36. China Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Country (2021–2032)
Figure 44. Latin America Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Treatment Drugs for Axial Spondyloarthritis Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Treatment Drugs for Axial Spondyloarthritis Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Treatment Drugs for Axial Spondyloarthritis Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Treatment Drugs for Axial Spondyloarthritis by Type (2021–2032)
Figure 55. Global Revenue Market Share of Treatment Drugs for Axial Spondyloarthritis by Type (2021–2032)
Figure 56. Global Treatment Drugs for Axial Spondyloarthritis Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Treatment Drugs for Axial Spondyloarthritis by Application (2021–2032)
Figure 58. Global Revenue Market Share of Treatment Drugs for Axial Spondyloarthritis by Application (2021–2032)
Figure 59. Global Treatment Drugs for Axial Spondyloarthritis Price (US$/Unit) by Application (2021–2032)
Figure 60. Treatment Drugs for Axial Spondyloarthritis Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
